Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,228,000 | 4,767,000 | 377,000 | 1,603,000 | -3,147,000 |
| Depreciation Amortization | 2,116,000 | 984,000 | 3,872,000 | 2,908,000 | 1,894,000 |
| Income taxes - deferred | -232,000 | -51,000 | -1,899,000 | -968,000 | -632,000 |
| Accounts receivable | N/A | N/A | -1,148,000 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -380,000 | N/A | N/A |
| Other Working Capital | -4,394,000 | -3,382,000 | -2,205,000 | -2,349,000 | -4,526,000 |
| Other Operating Activity | 1,009,000 | 772,000 | 14,389,000 | 11,566,000 | 11,454,000 |
| Operating Cash Flow | $8,727,000 | $3,090,000 | $13,006,000 | $12,760,000 | $5,043,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 256,000 | 245,000 | 703,000 | 785,000 | 198,000 |
| PPE Investments | -1,652,000 | -861,000 | -3,863,000 | -2,874,000 | -1,972,000 |
| Net Acquisitions | -746,000 | -746,000 | -12,032,000 | -12,032,000 | -12,032,000 |
| Sale Of Investment | N/A | N/A | 1,145,000 | N/A | N/A |
| Other Investing Activity | -303,000 | -14,000 | -36,000 | -15,000 | 4,000 |
| Investing Cash Flow | $-2,445,000 | $-1,376,000 | $-14,083,000 | $-14,136,000 | $-13,802,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,937,000 |
| Debt Issued | 3,600,000 | N/A | 5,939,000 | 5,939,000 | 5,946,000 |
| Debt Repayment | -751,000 | -751,000 | -1,755,000 | -1,752,000 | -1,751,000 |
| Common Stock Issued | 160,000 | 87,000 | 125,000 | 119,000 | 112,000 |
| Common Stock Repurchased | -373,000 | -122,000 | -1,346,000 | -953,000 | -487,000 |
| Dividend Paid | -3,936,000 | -1,950,000 | -7,445,000 | -5,593,000 | -3,738,000 |
| Other Financing Activity | -298,000 | -78,000 | -328,000 | -325,000 | -315,000 |
| Financing Cash Flow | $-1,598,000 | $-2,814,000 | $-4,810,000 | $-2,565,000 | $1,704,000 |
| Exchange Rate Effect | -220,000 | -138,000 | 23,000 | -163,000 | -6,000 |
| Beginning Cash Position | 6,909,000 | 6,909,000 | 12,773,000 | 12,773,000 | 12,773,000 |
| End Cash Position | 11,373,000 | 5,671,000 | 6,909,000 | 8,669,000 | 5,712,000 |
| Net Cash Flow | $4,464,000 | $-1,238,000 | $-5,864,000 | $-4,104,000 | $-7,061,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,727,000 | 3,090,000 | 13,006,000 | 12,760,000 | 5,043,000 |
| Capital Expenditure | -1,652,000 | -861,000 | -3,863,000 | -2,874,000 | -1,972,000 |
| Free Cash Flow | 7,075,000 | 2,229,000 | 9,143,000 | 9,886,000 | 3,071,000 |